Nautilus Biotechnology Inc
NASDAQ:NAUT
Nautilus Biotechnology Inc
NASDAQ:NAUT
Price:
3.91
USD
-1.01%
Market Cap:
$494.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nautilus Biotechnology Inc
NASDAQ:NAUT
|
US |
|
M
|
Medco Energi Internasional Tbk PT
IDX:MEDC
|
ID |
|
XPS Pensions Group PLC
LSE:XPS
|
UK |
|
Z
|
Zenas Biopharma Inc
NASDAQ:ZBIO
|
US |
|
Goldoz Ltd
ASX:G79
|
AU |
|
Hitachi Metals Ltd
TSE:5486
|
JP |
|
O
|
Optimi Health Corp
CNSX:OPTI
|
CA |
|
Longfor Group Holdings Ltd
HKEX:960
|
CN |
|
T
|
Texas Community Bancshares Inc
NASDAQ:TCBS
|
US |
|
Shan Dong Lubei Chemical Co Ltd
SSE:600727
|
CN |
|
Global Payments Inc
NYSE:GPN
|
US |
|
W
|
Warisan TC Holdings Bhd
KLSE:WARISAN
|
MY |
|
M
|
Mincon Group PLC
ISEQ:MIO
|
IE |
|
S
|
Soosan INT Co Ltd
KOSDAQ:050960
|
KR |
|
adesso SE
OTC:ADSGF
|
DE |
|
F
|
Function International PCL
SET:FTI
|
TH |
|
Senzime AB (publ)
STO:SEZI
|
SE |
|
M
|
MMAG Holdings Bhd
KLSE:MMAG
|
MY |
|
G
|
GTI Holdings Ltd
HKEX:3344
|
HK |
|
Berkeley Group Holdings PLC
LSE:BKG
|
UK |
Multiples-Based Value
The Multiples-Based Value of one
NAUT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.91 USD,
Nautilus Biotechnology Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NAUT Multiples-Based Value
LOCKED
Multiples Across Competitors
NAUT Competitors Multiples
Nautilus Biotechnology Inc Competitors
Nautilus Biotechnology Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Nautilus Biotechnology Inc
NASDAQ:NAUT
|
494.5m USD | 0 | -8.4 | -6 | -5.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
967B USD | 338.6 | 4 009 | 1 148.8 | 2 212.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.6B USD | 4.1 | 27.5 | 19.1 | 25.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.3B USD | 5.4 | 36.7 | 18.7 | 27.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.3B CHF | 5.2 | 35.8 | 26.6 | 26.6 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
268.9B CNY | 6.1 | 17.9 | 18 | 18 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.9B USD | 4.6 | 25 | 18.4 | 21.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.7B USD | 9.4 | 46.1 | 29.8 | 37.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.1B USD | 1.8 | 21.3 | 11.9 | 17.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.8B USD | 6.5 | 29.9 | 22.2 | 24.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
